medical

OpenAI has announced the launch of a new health-focused experience, "ChatGPT Health," where users can voluntarily connect their medical records with health apps like Apple Health and MyFitnessPal to receive personalized suggestions based on their health data.This feature aims to assist users in understanding test results, preparing for medical visits, and optimizing diet and exercise plans, while storing health data in a separate space to ensure privacy and security. A waitlist is now open, with initial access limited to a small number of users for testing.

According to Jinshi News, the gains of Hong Kong stock cryptocurrency concept stocks have expanded, with Huajian Medical surging over 13% in the afternoon, and OK Blockchain rising over 8%. Stocks such as Yunfeng Financial, Guotai Junan International, and OLS Group also followed suit.

华检医疗 (1931) announced the suspension of its planned cryptocurrency acquisition not exceeding 3 billion yuan, and will disclose Ethereum (ETH) transactions in accordance with listing rules in the future. At the same time, the acquisition of a 20.31% stake in Guofu Quantum (0290) for 3.142 billion yuan has been canceled.The company has adjusted its strategy, starting to apply for a U.S. stablecoin license and plans to raise funds to increase its dollar reserves, while simultaneously developing an AI algorithm platform that integrates the distribution network with the RWA platform to enhance the accuracy of asset valuation models.

According to the announcement from the Hong Kong Stock Exchange, Hong Kong-listed company Huajian Medical disclosed a potential major acquisition plan to acquire cryptocurrency for no more than 3 billion yuan, announced in mid-August, and planned to submit it for shareholder approval. However, it has not sent a circular to shareholders as scheduled, and there has been no progress after two and a half months.Huajian Medical stated that it requires additional time to obtain shareholder authorization and has temporarily suspended the major acquisition. In the future, when it continues to purchase ETH (Ethereum) in the market, it will disclose this in accordance with the listing rules of the Hong Kong Stock Exchange, particularly Chapter 14, which pertains to the disclosure of transactions. Huajian Medical added that its subsequent plan is to build an AI algorithm platform to improve recognition rates and intends to integrate its distribution network, ecosystem, and RWA platform to enhance the accuracy of the underlying asset valuation model and the efficiency and transparency of the securitization process.

ChainCatcher news, September 3, reported by Theblock, Hong Kong Fosun Wealth Holdings announced that it has completed the tokenization of shares in the Hong Kong-listed Sisram Medical, valued at approximately $328 million. The project was implemented through Vaulta's "Banking OS" system and integrated the Solana blockchain into its technology architecture for issuance and settlement.It is reported that Sisram Medical (stock code: 1696.HK) is an Israeli medical technology company and is the first equity project under this tokenization plan. Fosun stated that it will promote the tokenization of other corporate bonds and shares in the future, but has not yet disclosed a specific timetable or target companies.

ChainCatcher news, according to the Hong Kong Stock Exchange announcement, Hong Kong Ethereum treasury listed company Huajian Medical announced the acquisition of 20.31% equity in Guofu Quantum for approximately HKD 3.142 billion to advance its RWA exchange strategy. The transaction will be paid through the issuance of consideration shares, with an issue price of HKD 9.69 per share.Upon completion of the acquisition, Huajian Medical will become the major shareholder of Guofu Quantum and will incorporate it into its financial statements using the equity method. This acquisition is part of Huajian Medical's strategy to promote the RWA (Real World Asset) exchange, achieving a closed-loop ecosystem from the asset side to the trading side, and will lay out plans in the stablecoin market. In August of this year, Huajian Medical announced the official launch of a global enhanced Ethereum treasury strategy with a downside protection mechanism, positioning Ethereum as its core reserve asset.

ChainCatcher news, according to Zhitong Finance, Huajian Medical (01931.HK) announced that the board intends to seek approval from a special general meeting of shareholders to purchase cryptocurrencies for a total amount not exceeding HKD 3 billion within 36 months from the date of authorization.The company stated that this move aims to solidify the Ethereum reserve treasury and accelerate the ecological construction of the ivd.xyz exchange, as an important component of the group's asset allocation strategy.

ChainCatcher news, Hong Kong licensed virtual asset trading platform HashKey Exchange successfully held a strategic cooperation signing ceremony with Hong Kong listed company IVD Medical Holdings Limited in Hong Kong. IVD Medical, through HashKey Exchange's compliance services, completed the first batch of HKD 149 million in Ethereum asset allocation, becoming a benchmark for listed companies in Hong Kong to build enterprise-level digital asset portfolios.HashKey Exchange will serve as the core service provider, offering IVD Medical a one-stop digital asset solution, including large-scale over-the-counter (OTC) trading channels, global liquidity support, and exploring DeFi value-added solutions in collaboration with ecosystem partner HashKey Cloud, assisting IVD Medical in advancing industrial capital upgrades and medical asset tokenization.

ChainCatcher news, according to aastocks, Huajian Medical (stock code 01931) announced that it has officially launched the "Global Enhanced Ethereum Treasury with Downside Protection Mechanism" strategy.Based on strategic layout needs, Ethereum will be used as the core reserve asset, aiming to become the leading listed company in the Hong Kong stock market and even globally in terms of Ethereum reserve scale. The group will adopt a "regular investment" strategy to continuously increase its holdings of Ethereum through multiple funding sources, including its own funds, stable annual distributable profits, replacement of existing inefficient inventory assets, and ongoing financing through ATM (At-The-Market).

ChainCatcher news, according to Coindesk, Hong Kong-listed company IVD Medical Holdings announced the purchase of $19 million (approximately HKD 149 million) worth of Ethereum to support its medical asset tokenization strategy.The company is developing a platform based on Ethereum smart contracts, ivd.xyz, aimed at tokenizing pharmaceutical intellectual property and medical assets.

ChainCatcher news, Hong Kong listed company Huajian Medical (01931.HK) rose another 9% during the trading session, with a cumulative increase of over 200% in the past four weeks. As of the time of writing, it is up 7.3%, priced at HKD 6.17, with a trading volume of HKD 23.3243 million.According to previous news from ChainCatcher, Huajian Medical announced at the end of July that it had signed a strategic cooperation framework agreement with BGI CoWin to jointly establish the Huajian-BGI CoWin innovative drug intellectual property tokenization fund (IVD-BGI CoWin).

ChainCatcher news, Hong Kong listed company Huajian Medical announced that it has established a wholly-owned subsidiary IVD GROUP in the state of New York, USA. This American subsidiary will serve as the core operational entity to advance the IVDNewCo Exchange strategy in the United States.In addition, the American subsidiary has officially initiated the process of submitting a stablecoin license application to relevant regulatory agencies in the United States (including but not limited to the SEC and CFTC).This move is a substantial advancement of the group's "U.S. stablecoin license application plan" mentioned in the previous announcement, demonstrating the group's execution capability and foresight in global compliance布局.

ChainCatcher news, according to Bitcoin News, the Basel Medical Group has suspended its Bitcoin acquisition strategy due to the ongoing regulatory uncertainty surrounding digital assets in the United States.

ChainCatcher news, the official information disclosure system of the Hong Kong Stock Exchange shows that on July 17, Huajian Medical (01931.HK) announced the official launch of the "IVDNewCo Exchange" ecological plan, introducing an RWA exchange ecosystem focused on high-tech assets of innovative medical drugs NewCo and a supporting issuance plan for the IVDD stablecoin.It is reported that the company is actively promoting the construction of an "NewCo + RWA + Web3" exchange ecosystem centered on high-tech assets of innovative medical drugs, which will be named "IVDNewCo Exchange," along with the issuance of a proprietary stablecoin (IVDDollar "IVDD").This strategy aims to advance the development of the traditional pharmaceutical industry by integrating Web3 technologies (including RWA tokenization of real-world assets, blockchain trading, and stablecoin mechanisms) to enhance the liquidity, financing efficiency, and accessibility of global innovative medical drug assets.

ChainCatcher news, according to GlobeNewswire, Singapore-based orthopedic medical group Basel Medical (NASDAQ: BMGL) announced a purchase agreement with the Bitcoin Holders Alliance to acquire up to 10,000 BTC (currently valued at approximately $1 billion) through the issuance of common stock. This move aims to diversify the company's capital reserves while maintaining its core business expansion in medical services across the Asia-Pacific region. The group was established in Singapore and specializes in orthopedic trauma treatment and neurosurgery. The company stated that this strategic investment will strengthen its balance sheet and support its expansion plans in the high-growth healthcare market in Asia.

ChainCatcher news, according to Globe Newswire, the US-listed company Basel Medical Group Ltd announced today that it has initiated exclusive negotiations for a Bitcoin (BTC) acquisition plan totaling $1 billion. This plan will significantly diversify the company's financial reserves while continuing to focus on expansion in the medical services sector.

ChainCatcher news, according to Globenewswire, medical service provider SRx Health Solutions, Inc. (NYSE American: SRXH) announced that it has invested $1.5 million in Solana tokens (SOL) to advance its asset diversification strategy. The company has previously planned to allocate no more than 10% of its cash flow and cash reserves to invest in cryptocurrencies such as Bitcoin (BTC), Solana (SOL), and physical gold and silver. The company's chairman, Adesh Vora, stated that in addition to existing funds, they will continue to increase their allocation to crypto assets through asset sales, partnerships, and financing, and explore the introduction of a crypto rewards program in their pharmacy business.In addition, the company plans to establish a cryptocurrency lending subsidiary, intending to collateralize its Halo brand assets and future earnings to secure financing in cryptocurrencies such as Solana and Bitcoin. This move aims to avoid equity dilution in obtaining operating funds, which will be used for Halo brand marketing. Currently, the plan is still in the conceptual stage, and the company will further discuss implementation details with the crypto community.

ChainCatcher news, the decentralized data value infrastructure CESS Network has officially signed a cooperation agreement with the internationally leading health data platform HealthBanks Biotech, assisting in the on-chain storage of data related to blood banks, stem cells, and immunotherapy. This collaboration will fully utilize CESS's decentralized data infrastructure to ensure high privacy, high availability, and long-term integrity for medical data.By integrating with CESS's multi-layer blockchain network architecture, HealthBanks will achieve decentralized storage, access, and sharing of its critical life sciences data, driving the digital health sector towards a more transparent, trustworthy, and compliant future. This also marks an important milestone for CESS in the field of medical health data management, laying a solid foundation for the large-scale application of decentralized technology in the life sciences industry.

ChainCatcher news, according to Globe Newswire, the Japanese medical group SBC Medical Group Holdings announced that it has completed the purchase of 5 BTC, with the acquisition finalized on April 14, 2025.SBC Medical stated that Bitcoin is gaining attention as a new form of value storage, particularly for its potential to preserve value during inflationary periods. The company will continue to adhere to the principle of asset diversification and implement prudent financial management within a strict risk management framework.It is reported that SBC Medical's main business includes providing comprehensive management services for beauty clinics, with headquarters located in Irvine, California, and Tokyo, Japan.Previously, in February, SBC Medical announced plans to purchase Bitcoin worth 1 billion yen (approximately 6.7 million USD) to achieve its long-term strategic goals of asset diversification and combating inflation, with completion expected between February and May 2025.